The Claim
Biofilm-associated Staphylococcus aureus in diabetic foot ulcers evades immune clearance by suppressing perforin-2, masking pathogen-associated molecular patterns, and secreting virulence factors that activate inflammatory pathways such as NLRP3 and AIM2.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Staphylococcus aureus living in biofilms within diabetic foot ulcers reduces immune detection by inhibiting perforin-2, hiding molecular signatures, and releasing molecules that trigger inflammation through NLRP3 and AIM2 pathways.
See the scientific wording
Biofilm-associated Staphylococcus aureus in diabetic foot ulcers evades immune clearance by suppressing perforin-2, masking pathogen-associated molecular patterns, and secreting virulence factors that activate inflammatory pathways such as NLRP3 and AIM2.
Staphylococcus aureus forms a slimy shield that blocks immune cells from reaching the bacteria. Inside this shield, the bacteria hide from detection and stop the body from making a key weapon that kills them. The bacteria release toxins that damage tissue and trigger immune cells to overreact, causing persistent swelling and injury instead of healing. This constant inflammation prevents the wound from closing and lets the infection stay for months.
What the research says
1 studyIn diabetic foot ulcers, the bacteria Staphylococcus aureus hides inside cells and tricks the immune system into causing harmful inflammation instead of killing it, and this study shows exactly how that happens.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.